Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

400
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
400
Longitudinal Research02:20

Longitudinal Research

13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

632
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
632
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

310
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
310
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

468
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
468

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing surrogate heterogeneity in real world data using meta-learners.

Journal of causal inference·2026
Same author

Model-Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival.

Statistics in medicine·2025
Same author

RISE: Two-Stage Rank-Based Identification of High-Dimensional Surrogate Markers Applied to Vaccinology.

Statistics in medicine·2025
Same author

Semiparametric joint modeling to estimate the treatment effect on a longitudinal surrogate with application to chronic kidney disease trials.

Biometrics·2025
Same author

Access to medication treatment for opioid use disorder in fee-for-service medicare.

Health affairs scholar·2025
Same author

Robust evaluation of longitudinal surrogate markers with censored data.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2025

Related Experiment Video

Updated: Dec 19, 2025

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
08:16

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

Published on: May 9, 2016

11.0K

Evaluation of longitudinal surrogate markers.

Denis Agniel1, Layla Parast1

  • 1RAND Corporation.

Biometrics
|June 8, 2020
PubMed
Summary

This study introduces a new model-free approach to assess how well longitudinal surrogate markers predict treatment outcomes. It offers flexible estimation methods for analyzing treatment effectiveness in clinical trials using repeated measurements.

Keywords:
functional datakernel smoothinglongitudinal datanonparametric analysissurrogate markers

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K

Related Experiment Videos

Last Updated: Dec 19, 2025

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
08:16

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

Published on: May 9, 2016

11.0K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Surrogate markers can expedite treatment evaluation but existing methods often rely on strict assumptions and single time-point data.
  • Longitudinal surrogate markers, measured repeatedly over time, are common in clinical practice but challenging to analyze.
  • Specifying the complex relationships between treatment, outcomes, and surrogate trajectories is often difficult.

Purpose of the Study:

  • To propose a model-free definition for the proportion of treatment effect explained by longitudinal surrogate markers.
  • To develop novel, flexible statistical methods for estimating this proportion.
  • To evaluate the performance and robustness of these new methods.

Main Methods:

  • Developed a model-free definition for treatment effect proportion explained by longitudinal surrogates.
  • Proposed three novel, flexible statistical methods for estimation.
  • Investigated asymptotic properties and conducted simulation studies for robustness.

Main Results:

  • The proposed methods provide a flexible framework for analyzing longitudinal surrogate markers.
  • Simulation studies demonstrated the robustness of the proposed estimators under various settings.
  • The methods were successfully applied to an AIDS clinical trial dataset.

Conclusions:

  • The novel methods offer a valuable, assumption-free approach to assessing surrogate marker utility with longitudinal data.
  • This work enhances the ability to efficiently evaluate treatments using repeated surrogate marker measurements.
  • The application to AIDS data highlights the practical utility in real-world clinical research.